TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
PGNY

Progyny Inc

Healthcare · Healthcare Plans

29.40$ +0.8% vs. previous close Closing price · As of: Nov 2, 2026

Ownership

Ownership Structure

Who owns Progyny Inc (PGNY)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 91.5% of the shares are freely tradable; institutional investors hold 112.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 112.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.9%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 91.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 9.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 77Mio.

Largest Shareholders

Institutions

Institutions PGNY
Name Stake (%) Shares Change (%) Date
BlackRock Inc 14.99 11,599,921 -3.3 06/30/2026
FMR Inc 9.05 7,004,280 +7.7 06/30/2026
Vanguard Portfolio Management, LLC 6.49 5,019,465 -5.2 06/30/2026
Vanguard Capital Management, LLC 4.15 3,210,723 -7.8 06/30/2026
State Street Corp 3.91 3,022,859 -1.9 06/30/2026
Ameriprise Financial Inc 3.57 2,763,514 -2.2 06/30/2026
Geode Capital Management, LLC 2.54 1,969,208 -3.6 06/30/2026

Funds

Funds PGNY
Name Stake (%) Shares Change (%) Date
iShares Core S&P Small-Cap ETF 5.90 4,566,776 +0.0 09/30/2026
Vanguard MStar Total Stk Mkt Idx Invest 2.92 2,257,404 +0.4 09/30/2026
Avantis US Small Cap Value ETF 2.49 1,928,807 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings PGNY
Person Role Shares Value As of Type
Anevski Peter CHIEF EXECUTIVE OFFICER 806,111 23,699,663 $ Sep 3, 2026 direct
Swartz Allison EVP, GC 75,816 2,228,990 $ Sep 23, 2026 direct
Livingston Mark S. CHIEF FINANCIAL OFFICER 72,453 2,130,118 $ Sep 4, 2026 direct
Cummings Melissa B Chief Operating Officer 66,496 1,954,982 $ Oct 14, 2026 direct
Clapp Geoffrey Chief Product Officer 59,009 1,734,865 $ Sep 17, 2026 direct
Gordon Kevin K Director 6,792 199,685 $ Sep 10, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Oct 14, 2026 Cummings Melissa B Chief Operating Officer Sell 1,879 28.00 52,612
Oct 14, 2026 Cummings Melissa B Chief Operating Officer Other 1,559 27.39 42,701
Sep 23, 2026 Swartz Allison EVP, GC Sell 3,903 26.10 101,868
Sep 17, 2026 Clapp Geoffrey Chief Product Officer Other 819 27.38 22,424
Sep 10, 2026 Gordon Kevin K Director Sell 11,500 27.94 321,358
Sep 10, 2026 Gordon Kevin K Director Other 10,500 27.24 286,020
Sep 10, 2026 Gordon Kevin K Director Other 22,000 13.00 286,000
Sep 4, 2026 Swartz Allison EVP, GC Other 479 26.61 12,746
Sep 4, 2026 Livingston Mark S. CHIEF FINANCIAL OFFICER Other 479 26.61 12,746
Sep 3, 2026 Anevski Peter CHIEF EXECUTIVE OFFICER Other 5,361 26.29 140,941
Sep 3, 2026 Swartz Allison EVP, GC Other 828 26.29 21,768
Sep 3, 2026 Livingston Mark S. CHIEF FINANCIAL OFFICER Other 1,532 26.29 40,276
Sep 2, 2026 Livingston Mark S. CHIEF FINANCIAL OFFICER Other 224 25.66 5,748
Aug 28, 2026 Swartz Allison EVP, GC Other 1,352 25.86 34,963
Jul 14, 2026 Cummings Melissa B Chief Operating Officer Sell 2,244 31.60 70,910
Jul 14, 2026 Cummings Melissa B Chief Operating Officer Other 1,193 31.98 38,152

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?